Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.32) per share. This is a 72.88 percent increase over losses of $(1.18) per share from the same period last year. The company reported quarterly sales of $646.635 thousand which missed the analyst consensus estimate of $2.229 million by 70.99 percent. This is a 19.68 percent decrease over sales of $805.110 thousand the same period last year.
Neuraxis Q1 2024 GAAP EPS $(0.32) Up From $(1.18) YoY, Sales $646.635K Miss $2.229M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.